223 related articles for article (PubMed ID: 37704111)
1. Expanding the ubiquitin code in pancreatic cancer.
Yang W; Wang S; Tong S; Zhang WD; Qin JJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166884. PubMed ID: 37704111
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination and deubiquitination: Implications on cancer therapy.
Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
[TBL] [Abstract][Full Text] [Related]
3. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
Goru SK; Kadakol A; Gaikwad AB
Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
[TBL] [Abstract][Full Text] [Related]
4. Role of the ubiquitin proteasome system in hematologic malignancies.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy.
Liu Q; Aminu B; Roscow O; Zhang W
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466790
[TBL] [Abstract][Full Text] [Related]
6. A patent review of the ubiquitin ligase system: 2015-2018.
Li X; Elmira E; Rohondia S; Wang J; Liu J; Dou QP
Expert Opin Ther Pat; 2018 Dec; 28(12):919-937. PubMed ID: 30449221
[TBL] [Abstract][Full Text] [Related]
7. The Multifaceted Role of the Ubiquitin Proteasome System in Pathogenesis and Diseases.
Stekel Z; Sheng Y; Zhang W
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883481
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-Proteasome Pathway and Muscle Atrophy.
Khalil R
Adv Exp Med Biol; 2018; 1088():235-248. PubMed ID: 30390254
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
10. E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers.
Chang SC; Zhang BX; Ding JL
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188679. PubMed ID: 35074437
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.
Allende-Vega N; Saville MK
Semin Cancer Biol; 2010 Feb; 20(1):29-39. PubMed ID: 19897040
[TBL] [Abstract][Full Text] [Related]
12. Tripartite Split-GFP for High Throughput Screening of Small Molecules: A Powerful Strategy for Targeting Transient/Labile Interactors like E2-E3 Ubiquitination Enzymes.
Polge C; Cabantous S; Taillandier D
Chembiochem; 2024 Mar; 25(6):e202300723. PubMed ID: 38088048
[TBL] [Abstract][Full Text] [Related]
13. Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
Liess AKL; Kucerova A; Schweimer K; Schlesinger D; Dybkov O; Urlaub H; Mansfeld J; Lorenz S
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082289
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of Ubiquitination in Differentiation and Dedifferentiation of Pancreatic β-cells: Putative Target for Diabetes.
Francis M; Bhaskar S; Vishnuvajhala S; Prasanna J; Kumar A
Curr Protein Pept Sci; 2022; 23(9):602-618. PubMed ID: 35466872
[TBL] [Abstract][Full Text] [Related]
15. In vitro autoubiquitination activity of E3 ubiquitin ligases of the N-degron pathway.
Sandmann A; Dissmeyer N
Methods Enzymol; 2023; 686():205-220. PubMed ID: 37532400
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Zhao CX; Zeng CM; Wang K; He QJ; Yang B; Zhou FF; Zhu H
Acta Pharmacol Sin; 2021 Feb; 42(2):179-188. PubMed ID: 32601365
[TBL] [Abstract][Full Text] [Related]
17. Proteasome substrate receptors and their therapeutic potential.
Osei-Amponsa V; Walters KJ
Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
[TBL] [Abstract][Full Text] [Related]
18. A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development.
Magnati S; Alladio E; Bracco E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397039
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Ubiquitin-Proteasome System and Recent Advances in Cancer Therapy.
Spano D; Catara G
Cells; 2023 Dec; 13(1):. PubMed ID: 38201233
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
